352 related articles for article (PubMed ID: 24043904)
1. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
[TBL] [Abstract][Full Text] [Related]
2. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
[TBL] [Abstract][Full Text] [Related]
3. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
Stagg J; Divisekera U; McLaughlin N; Sharkey J; Pommey S; Denoyer D; Dwyer KM; Smyth MJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1547-52. PubMed ID: 20080644
[TBL] [Abstract][Full Text] [Related]
5. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
[TBL] [Abstract][Full Text] [Related]
6. A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy.
Qiao Z; Li X; Kang N; Yang Y; Chen C; Wu T; Zhao M; Liu Y; Ji X
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823477
[TBL] [Abstract][Full Text] [Related]
7. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.
Zhi X; Chen S; Zhou P; Shao Z; Wang L; Ou Z; Yin L
Clin Exp Metastasis; 2007; 24(6):439-48. PubMed ID: 17587186
[TBL] [Abstract][Full Text] [Related]
8. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
9. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
10. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF
Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells.
Zhi X; Wang Y; Zhou X; Yu J; Jian R; Tang S; Yin L; Zhou P
Cancer Sci; 2010 Dec; 101(12):2561-9. PubMed ID: 20874842
[TBL] [Abstract][Full Text] [Related]
12. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Turcotte M; Allard D; Mittal D; Bareche Y; Buisseret L; José V; Pommey S; Delisle V; Loi S; Joensuu H; Kellokumpu-Lehtinen PL; Sotiriou C; Smyth MJ; Stagg J
Cancer Res; 2017 Oct; 77(20):5652-5663. PubMed ID: 28855210
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix.
Zhou P; Zhi X; Zhou T; Chen S; Li X; Wang L; Yin L; Shao Z; Ou Z
Cancer Biol Ther; 2007 Mar; 6(3):426-31. PubMed ID: 17471030
[TBL] [Abstract][Full Text] [Related]
14. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
[TBL] [Abstract][Full Text] [Related]
15. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
[TBL] [Abstract][Full Text] [Related]
16. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
[TBL] [Abstract][Full Text] [Related]
17. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.
Airas L; Niemelä J; Jalkanen S
J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892
[TBL] [Abstract][Full Text] [Related]
18. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
Lin J; Huo R; Wang L; Zhou Z; Sun Y; Shen B; Wang R; Li N
Cancer Immunol Immunother; 2012 May; 61(5):677-87. PubMed ID: 22048717
[TBL] [Abstract][Full Text] [Related]
19. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
Sadej R; Spychala J; Skladanowski AC
Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268
[TBL] [Abstract][Full Text] [Related]
20. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
